Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

86.90
BATS BZX Real-Time Price
As of 1:50pm ET
 +2.48 / +2.94%
Today’s Change
75.90
Today|||52-Week Range
143.45
-30.94%
Year-to-Date
A Heavy Hitter Just Stepped Up to the Cystic Fibrosis Plate
May 20 / MotleyFool.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, T...
May 19 / Zacks.com - Paid Partner Content
Nivalis Starts Dosing in Second Phase II Cystic Fibrosis Study
May 17 / Zacks.com - Paid Partner Content
Carlson Reduces Holdings in Monsanto and eBay in st Quarter
May 18 / GuruFocus News - Paid Partner Content
Pioneer climbs on oil output optimism
Apr 26 / FT.com - Paid Partner Content

Today’s Trading

Previous close84.42
Today’s open84.80
Day’s range83.62 - 87.17
Volume32,588
Average volume (3 months)2,461,063
Market cap$20.9B
Dividend yield--
Data as of 1:50pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+26.43%
Earnings growth (this year)+199.74%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+77.86%
P/E ratioNM
Price/Sales29.41
Price/Book22.12

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+1.09+2.64%
ZTSZoetis Inc+0.88+1.90%
INCYIncyte Corp+0.10+0.12%
BMRNBiomarin Pharmaceuti...+2.34+2.74%
Data as of 1:50pm ET, 05/24/2016

Financials

Next reporting dateJuly 25, 2016
EPS forecast (this quarter)$0.22
Annual revenue (last year)$1.0B
Annual profit (last year)-$556.3M
Net profit margin-53.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs